Introduction mutational signature has also been described that has been attributed to the action 1 capture these differences, we stratified analyses of mutational spectra based on 2 distance between the variants. The distance between the two variants that make up 3 an MNV will be denoted as a subscript. For example, adjacent MNVs will be referred 4 to as MNV1bp. MNVs can be created by either a single mutational event or by 5 consecutive mutational events. For MNVs that were created by a single mutational 6 event, the pair of variants are likely to have identical allele frequencies as they are 7 unlikely to occur in the population separately (we assume recurrent mutations and 8 reversions are rare). The proportion of nearby pairs of SNVs with identical allele 9 frequencies that phase to the same haplotype remains close to 100% even at a 10 distance of 100bp apart ( Figure 1b ). We can assume that these variants most likely 11 arose simultaneously and will be referred to as sim-MNVs. The proportion of pairs of
12
SNVs with different allele frequencies that phase to the same haplotype approaches 13 50% at around 20bp. These probably arose consecutively and will be referred to as same generation. 
21
Analysis of MNV mutational spectra confirms mutational origins.
22
Differences in mutational spectra across different subsets of MNVs can reveal 23 patterns or signatures left by the underlying mutational mechanism. We analysed For sim-MNVs the proportion of variants that fell into these groups were 51%, 12% 1 and 37% respectively. For con-MNVs, most variants were further away with the 2 proportions being 10%,7% and 83% (Table 1) . We observed significant differences 3 between the mutational spectra of sim-MNVs and con-MNVs (Figure S1a, S1c). 
13
APOBEC are a family of cytosine deaminases that are known to cause clustered 14 mutations in exposed stretches of single-stranded DNA. These mutational mutations were found in pairs of variants that were a larger distance apart (10-50bp).
23
C…C -> T…T was also the most prolific mutation in sim-MNV3-20bp and had a 24 significantly larger proportion of APOBEC motifs in both variants compared to con-25 MNV3-20bp (p value 0.0056) ( Figure S1e ). The mutation C…C -> T…T was the most 26 frequent de novo MNV2-20bp ( Figure S2c ). However only three of the twelve de novo 27 MNV2-20bp had APOBEC motifs.
29
Mutational signatures in con-MNVs were primarily driven by CpG sites. In humans, 30 the 5' C in a CpG context is usually methylated and has a mutation rate that is 31 approximately ten-fold higher than any other context(Duncan and Miller 1980). For 1 con-MNV2-30bp the most common mutation is C…C->T…T and is driven by two 2 mutated CpG sites CG…CG> TG…TG (S1d). For con-MNV1bps, 24% are accounted 3 for by the mutation CA->TG, and its reverse complement (S1b). These adjacent 4 consecutive mutations most likely came about due to a creation of a CpG site by the 5 first mutation. If the first mutation creates a CpG then the mutations would be 6 expected to arise in a specific order: CA>CG>TG. We would therefore expect that 7 the A>G mutation would happen first and that variant would have a higher allele 8 frequency than the subsequent C>T. This was the case for 96% of the 1,445 CA>TG 9 con-MNV1bps. This was also the case for 96% and 92% of the other less common 10 possible CpG creating con-MNVs CC>TG and AG>CA. CA>TG is probably the 11 most common variant as it relies on a transition mutation A>G happening first which 12 has a higher mutation rate compared to the transversions C>G and T>G. We also 13 observed that for con-MNV1-3bps that were not as a result of CpG creating sites, the 14 first variant increases the mutability of the second variant more than expected by 15 chance. We compared the median difference in mutation probability of the second 16 variant based on the heptanucleotide sequence context before and after the first 
18
The median increase in mutation probability of the second variant was 0.0002
19
(signed Wilcoxon rank test p-value 9.8x10 -17 ).
21
Functional Consequences of MNVs
22
The structure of the genetic code is not random. The code has evolved such that the 23 codons that correspond to amino acids with similar physiochemical properties are 24 more likely to be separated by a single base change(Amirnovin 1997; Wong 1975).
25
SNVs that result in a missense change will only alter one of the bases in a codon, 26 however MNVs that alter a single codon ('intra-codon' MNVs) will alter two of the 27 three base pairs. Therefore they are more likely to introduce an amino acid that is 28 further away in the codon table and thus less similar physicochemically to the 29 original amino acid. Most intra-codon MNVs result in a missense change (Table 2) . 
12
We assessed the differences in the amino acid changes between exclusive missense and Braun 2001). We chose this measure as it does not depend on observed 18 substitution frequencies which may create a bias due to the low MNV mutation rate 19 making these amino acid changes inherently less likely. We found that the median 20 amino acid distance was significantly larger for two-step missense MNVs when impacting on a single codon. We observed that the proportion of inter-codon MNV1-12 20bp that fall in highly constrained genes (pLI>0.9) is significantly smaller compared to 13 missense SNVs (p-value 0.0007) ( Figure 3a ). For intra-codon MNVs, we saw that the 14 proportion of two-step missense MNVs observed in highly constrained genes was 15 also significantly smaller than for missense SNVs (p-value: 0.0016). 10 increase of about two in the interpolated CADD score. This is concordant with the 11 increase in CADD scores that was computed directly above.
13
Contribution of de novo MNVs to developmental disorders
14
We estimate the genome-wide mutation rate of sim-MNV1-20bp to be 1. 
29
We also estimated the MNV mutation rate using the set of de novo MNVs that fell 30 into non-constrained genes (pLI<0.1) that have not previously been associated with 1 estimate of 1.80x10 -10 (confidence interval 0.88, 2.70 x 10 -10 ) mutations per base pair 2 per generation, very similar to the estimate based on segregating polymorphisms 3 described above.
5
We identified 10 de novo MNVs within genes known to be associated with dominant 6 developmental disorders (DD-associated) in the DDD trios (Table 3) 1 codons within a protein are likely, on average, to have a greater functional impact 2 than SNVs that alter a single codon. We evaluated the functional impact of intra-3 codon MNVs using three complementary approaches: (i) depletion within genes 4 under strong selective constraint, (ii) shift towards rarer alleles in the site frequency 5 spectrum and (iii) enrichment of de novo mutations in known DD-associated genes 6 in children with DDs. We demonstrated that intra-codon MNVs also tend to have a 7 larger functional impact than SNVs, and that MNV missense changes that cannot be 8 achieved by a single SNV are, on average, more deleterious than those that can.
9
This is most likely due to the fact that they are on average more physico-chemically 
28
Those that could not be phased were discarded. Read based phasing for these 29 variants proved to be more error-prone than trio-based phasing and so was not performed. After examining the properties of these MNVs we restricted the analyses 1 to those that were 1-20bp of each other. We identified 69,940 unique MNVs. 
24
( Figure S3 ). Significance of these statistical tests was evaluated using a Bonferroni 25 corrected p-value threshold of 0.05/12 to take into account the 12 tests across all 26 three subsets of genes, SNV consequence types and MNVs ( Figure S3 ). To correct 27 for sequence context when comparing DD genes and non-DD genes, we adjusted 28 the expected number of MNVs in the DD genes category based on the excess of 29 polymerase zeta dinucleotide contexts. We also estimated the MNV mutation rate using all variants as well as a more stringent estimate just using variants that fell into 1 non-coding regions. When we redid the enrichment analysis using these mutation 2 rate estimates of varying stringency, the enrichment of de novo MNVs in DD-3 associated genes remained significant (all variants p-value: 2.7x10 -4 , non coding 4 control regions p-value: 4.9x10 -3 , Figure S4a ). The SNV mutation rate estimate 5 varies across studies therefore we also recalculated the MNV mutation rates using 6 SNV mutation rate estimates of 1.0x10 -8 and 1.2x10 -8 mutations per base pair per 7 generation (Segurel, Wyman, and Przeworski 2014). These were also recalculated 8 across the three different variant subsets (all variants, excluding variants in genes 9 with pLI>0.1, variants in non-coding control regions). The enrichment ratio of de 10 novo MNVs that fall into DD genes ranged from 2.7 to 4.8 however always remained 11 significantly greater than 1 and the confidence intervals consistently overlapped with 12 that of the SNV missense enrichment ratio ( Figure S4b ).
14
Analysis of the number of clinically reported de novo MNVs
15
We downloaded all clinically reported variants from the website ClinVar and 16 subsetted these variants to those that fell into autosomal dominant DDG2P genes 17 and those that were annotated as 'definitely pathogenic' or 'likely pathogenic'. This 18 set was then subsetted to 321 genes with at least one pathogenic missense 19 mutation. This was to ensure that missense mutations cause disease in these genes.
20
We then counted the numbers of SNV missense variants and used this to estimate 21 the number of expected missense MNVs across those genes. This was scaled using 22 the ratio of the SNV to MNV missense mutation rate across these genes. The MNV 23 missense mutation rate calculated as:
24
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Where 2/3 is the probability of an MNV falling within a codon and 0.97 is the 26 probability that a within-codon MNV results in a missense change. The expected 27 number of missense MNVs in DDG2P genes was then calculated as follows:
28
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